Sumant Inamdar
Concepts (283)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholangiopancreatography, Endoscopic Retrograde | 17 | 2024 | 87 | 5.430 |
Why?
| Pancreatitis | 11 | 2023 | 58 | 4.960 |
Why?
| Cholangitis | 3 | 2019 | 11 | 1.890 |
Why?
| Drainage | 8 | 2022 | 79 | 1.730 |
Why?
| Pancreatitis, Chronic | 3 | 2023 | 10 | 1.610 |
Why?
| Biliary Tract | 3 | 2023 | 12 | 1.470 |
Why?
| Barrett Esophagus | 9 | 2021 | 28 | 1.450 |
Why?
| Cholestasis | 2 | 2022 | 45 | 1.360 |
Why?
| Bile Ducts | 2 | 2017 | 53 | 1.100 |
Why?
| Endosonography | 10 | 2022 | 96 | 1.000 |
Why?
| Gastroenterology | 3 | 2022 | 20 | 0.960 |
Why?
| Humans | 73 | 2024 | 54284 | 0.930 |
Why?
| Postoperative Complications | 5 | 2020 | 1033 | 0.910 |
Why?
| Liver | 2 | 2021 | 1225 | 0.820 |
Why?
| Child Mortality | 1 | 2021 | 13 | 0.820 |
Why?
| Cholestasis, Intrahepatic | 1 | 2021 | 8 | 0.790 |
Why?
| Infant Mortality | 1 | 2021 | 70 | 0.780 |
Why?
| Sphincterotomy, Endoscopic | 3 | 2022 | 15 | 0.780 |
Why?
| Stents | 8 | 2021 | 375 | 0.780 |
Why?
| Esophageal Neoplasms | 5 | 2021 | 100 | 0.770 |
Why?
| Peritonitis | 2 | 2022 | 33 | 0.770 |
Why?
| Gastric Bypass | 2 | 2024 | 22 | 0.760 |
Why?
| Duodenal Neoplasms | 1 | 2020 | 15 | 0.750 |
Why?
| Hospitalization | 9 | 2023 | 705 | 0.750 |
Why?
| Pancreas | 5 | 2023 | 80 | 0.750 |
Why?
| Endoscopy, Digestive System | 6 | 2021 | 53 | 0.740 |
Why?
| Cholecystitis | 1 | 2019 | 13 | 0.730 |
Why?
| Intestinal Perforation | 1 | 2019 | 26 | 0.720 |
Why?
| Endoscopy, Gastrointestinal | 9 | 2024 | 75 | 0.710 |
Why?
| Fatty Liver | 1 | 2021 | 129 | 0.710 |
Why?
| Postoperative Hemorrhage | 1 | 2019 | 53 | 0.710 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 142 | 0.680 |
Why?
| Pancreatic Neoplasms | 4 | 2023 | 234 | 0.660 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 1 | 2017 | 8 | 0.620 |
Why?
| Retrospective Studies | 20 | 2024 | 6432 | 0.600 |
Why?
| Risk Factors | 11 | 2022 | 3935 | 0.600 |
Why?
| Eosinophilia | 1 | 2017 | 39 | 0.590 |
Why?
| Colonoscopy | 2 | 2018 | 105 | 0.590 |
Why?
| Indomethacin | 1 | 2016 | 40 | 0.580 |
Why?
| Bile Duct Diseases | 1 | 2016 | 11 | 0.570 |
Why?
| Needles | 1 | 2016 | 30 | 0.570 |
Why?
| Pregnancy Complications | 1 | 2021 | 384 | 0.560 |
Why?
| Biliary Tract Neoplasms | 1 | 2016 | 8 | 0.560 |
Why?
| Gastrointestinal Hemorrhage | 4 | 2021 | 79 | 0.550 |
Why?
| Surgery, Computer-Assisted | 1 | 2016 | 53 | 0.540 |
Why?
| Pancreaticoduodenectomy | 1 | 2015 | 13 | 0.530 |
Why?
| Jejunum | 1 | 2015 | 56 | 0.510 |
Why?
| Risk Assessment | 8 | 2021 | 1361 | 0.510 |
Why?
| Pancreatic Diseases | 3 | 2020 | 16 | 0.500 |
Why?
| Hemorrhage | 1 | 2016 | 208 | 0.490 |
Why?
| Endoscopy | 4 | 2019 | 131 | 0.490 |
Why?
| Female | 29 | 2023 | 28441 | 0.490 |
Why?
| Precancerous Conditions | 3 | 2020 | 93 | 0.470 |
Why?
| Liver Cirrhosis | 1 | 2016 | 216 | 0.470 |
Why?
| Male | 29 | 2023 | 27334 | 0.450 |
Why?
| Length of Stay | 5 | 2022 | 683 | 0.450 |
Why?
| Microscopy, Confocal | 5 | 2021 | 110 | 0.430 |
Why?
| Catheter Ablation | 3 | 2020 | 131 | 0.420 |
Why?
| Aged | 17 | 2021 | 10054 | 0.410 |
Why?
| Lipase | 2 | 2021 | 18 | 0.400 |
Why?
| Laparoscopy | 3 | 2024 | 188 | 0.400 |
Why?
| Middle Aged | 19 | 2023 | 13088 | 0.390 |
Why?
| Duodenoscopes | 2 | 2020 | 3 | 0.380 |
Why?
| Smoking | 1 | 2015 | 556 | 0.370 |
Why?
| Acute Disease | 4 | 2023 | 403 | 0.370 |
Why?
| Treatment Outcome | 9 | 2023 | 5604 | 0.360 |
Why?
| Adenomatous Polyps | 2 | 2020 | 9 | 0.350 |
Why?
| Adenocarcinoma | 3 | 2018 | 428 | 0.350 |
Why?
| Pancreatic Ducts | 2 | 2019 | 11 | 0.350 |
Why?
| Gallbladder | 2 | 2019 | 24 | 0.340 |
Why?
| Multicenter Studies as Topic | 2 | 2023 | 91 | 0.340 |
Why?
| Colonic Polyps | 2 | 2020 | 43 | 0.340 |
Why?
| United States | 9 | 2023 | 5217 | 0.340 |
Why?
| Cryotherapy | 2 | 2019 | 16 | 0.330 |
Why?
| Adult | 14 | 2023 | 14207 | 0.330 |
Why?
| Databases, Factual | 5 | 2022 | 684 | 0.330 |
Why?
| Hospital Mortality | 3 | 2022 | 465 | 0.310 |
Why?
| Inpatients | 2 | 2022 | 204 | 0.310 |
Why?
| Cryosurgery | 2 | 2017 | 38 | 0.300 |
Why?
| Esophagoscopy | 4 | 2021 | 26 | 0.290 |
Why?
| Pneumonia, Viral | 2 | 2020 | 184 | 0.290 |
Why?
| Pandemics | 3 | 2020 | 579 | 0.290 |
Why?
| Aged, 80 and over | 8 | 2021 | 3431 | 0.290 |
Why?
| Time Factors | 3 | 2021 | 3213 | 0.290 |
Why?
| Coronavirus Infections | 2 | 2020 | 192 | 0.290 |
Why?
| Patient Selection | 2 | 2019 | 286 | 0.280 |
Why?
| Abdominal Pain | 2 | 2023 | 77 | 0.280 |
Why?
| New York | 4 | 2020 | 50 | 0.260 |
Why?
| Pancreatic Cyst | 2 | 2022 | 13 | 0.260 |
Why?
| Pancreatitis, Acute Necrotizing | 2 | 2021 | 6 | 0.250 |
Why?
| Computer Systems | 1 | 2004 | 21 | 0.240 |
Why?
| Education, Medical, Graduate | 2 | 2020 | 225 | 0.240 |
Why?
| Quality of Life | 3 | 2023 | 922 | 0.240 |
Why?
| Crohn Disease | 2 | 2015 | 96 | 0.240 |
Why?
| Patient Readmission | 3 | 2022 | 242 | 0.240 |
Why?
| Esters | 1 | 2023 | 25 | 0.240 |
Why?
| Guanidines | 1 | 2023 | 36 | 0.240 |
Why?
| Nitrogen | 3 | 2019 | 78 | 0.230 |
Why?
| Esophageal Diseases | 1 | 2023 | 24 | 0.230 |
Why?
| Food | 1 | 2023 | 67 | 0.230 |
Why?
| Polyps | 2 | 2020 | 19 | 0.230 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 35 | 0.220 |
Why?
| Cystadenoma, Serous | 1 | 2022 | 5 | 0.220 |
Why?
| Education, Medical, Undergraduate | 1 | 2004 | 86 | 0.220 |
Why?
| Severity of Illness Index | 3 | 2020 | 1084 | 0.220 |
Why?
| Gastric Mucosa | 3 | 2017 | 59 | 0.220 |
Why?
| Sutures | 1 | 2022 | 45 | 0.210 |
Why?
| Pancreatic Pseudocyst | 2 | 2018 | 7 | 0.210 |
Why?
| Registries | 2 | 2022 | 553 | 0.210 |
Why?
| Suture Techniques | 1 | 2022 | 70 | 0.210 |
Why?
| Portasystemic Shunt, Surgical | 1 | 2021 | 5 | 0.210 |
Why?
| Life Tables | 1 | 2021 | 8 | 0.210 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2021 | 2 | 0.210 |
Why?
| Poliovirus Vaccines | 1 | 2021 | 3 | 0.210 |
Why?
| Measles Vaccine | 1 | 2021 | 6 | 0.210 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2022 | 596 | 0.200 |
Why?
| Internet | 1 | 2004 | 275 | 0.200 |
Why?
| Students, Medical | 1 | 2004 | 173 | 0.200 |
Why?
| Periodicals as Topic | 1 | 2022 | 65 | 0.190 |
Why?
| Image-Guided Biopsy | 1 | 2021 | 35 | 0.190 |
Why?
| Biopsy, Large-Core Needle | 1 | 2021 | 31 | 0.190 |
Why?
| Predictive Value of Tests | 2 | 2021 | 1048 | 0.190 |
Why?
| Hepatitis E | 1 | 2020 | 5 | 0.190 |
Why?
| Duodenoscopy | 1 | 2020 | 2 | 0.190 |
Why?
| Young Adult | 3 | 2021 | 4318 | 0.190 |
Why?
| Hepatitis E virus | 1 | 2020 | 9 | 0.190 |
Why?
| Gastrointestinal Diseases | 1 | 2022 | 126 | 0.190 |
Why?
| Cause of Death | 1 | 2021 | 165 | 0.190 |
Why?
| Severe Acute Respiratory Syndrome | 1 | 2020 | 15 | 0.190 |
Why?
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2022 | 49 | 0.190 |
Why?
| Prevalence | 2 | 2020 | 1025 | 0.190 |
Why?
| Recurrence | 2 | 2022 | 690 | 0.180 |
Why?
| Child | 3 | 2021 | 7341 | 0.180 |
Why?
| Disinfection | 1 | 2019 | 12 | 0.180 |
Why?
| RNA, Viral | 1 | 2020 | 141 | 0.180 |
Why?
| Equipment Contamination | 1 | 2019 | 26 | 0.180 |
Why?
| Anemia | 1 | 2020 | 84 | 0.180 |
Why?
| Esophageal Sphincter, Lower | 1 | 2019 | 2 | 0.180 |
Why?
| Cholecystitis, Acute | 1 | 2019 | 11 | 0.180 |
Why?
| Hepatitis C, Chronic | 1 | 2020 | 89 | 0.170 |
Why?
| Esophageal Achalasia | 1 | 2019 | 6 | 0.170 |
Why?
| Nursing Homes | 2 | 2010 | 126 | 0.170 |
Why?
| Plastics | 1 | 2018 | 14 | 0.170 |
Why?
| Clinical Trials as Topic | 1 | 2022 | 490 | 0.170 |
Why?
| Ambulatory Surgical Procedures | 1 | 2019 | 52 | 0.170 |
Why?
| Ultrasonography | 1 | 2021 | 480 | 0.170 |
Why?
| Prosthesis Implantation | 1 | 2018 | 47 | 0.160 |
Why?
| Liver Transplantation | 1 | 2020 | 160 | 0.160 |
Why?
| Prospective Studies | 5 | 2023 | 2604 | 0.160 |
Why?
| Learning Curve | 1 | 2017 | 22 | 0.160 |
Why?
| Cohort Studies | 3 | 2021 | 1543 | 0.160 |
Why?
| Pancreatectomy | 1 | 2017 | 18 | 0.160 |
Why?
| Cholecystectomy, Laparoscopic | 1 | 2017 | 24 | 0.160 |
Why?
| Gastric Antral Vascular Ectasia | 1 | 2017 | 2 | 0.160 |
Why?
| Choledocholithiasis | 1 | 2017 | 12 | 0.160 |
Why?
| Stomach Neoplasms | 1 | 2020 | 173 | 0.150 |
Why?
| Administration, Rectal | 1 | 2016 | 10 | 0.150 |
Why?
| Esophageal Stenosis | 1 | 2016 | 7 | 0.140 |
Why?
| Prosthesis Failure | 1 | 2017 | 113 | 0.140 |
Why?
| Lasers | 1 | 2017 | 141 | 0.140 |
Why?
| Device Removal | 1 | 2017 | 97 | 0.140 |
Why?
| Multivariate Analysis | 2 | 2016 | 643 | 0.140 |
Why?
| Abscess | 1 | 2016 | 42 | 0.140 |
Why?
| Colonic Neoplasms | 1 | 2018 | 164 | 0.140 |
Why?
| Pain | 1 | 2019 | 405 | 0.130 |
Why?
| Costs and Cost Analysis | 1 | 2016 | 109 | 0.130 |
Why?
| Anesthesia | 1 | 2016 | 79 | 0.130 |
Why?
| Gastrointestinal Neoplasms | 1 | 2015 | 46 | 0.130 |
Why?
| Ticlopidine | 1 | 2015 | 57 | 0.130 |
Why?
| Anastomosis, Surgical | 1 | 2015 | 72 | 0.130 |
Why?
| Time-to-Treatment | 1 | 2016 | 74 | 0.130 |
Why?
| Chi-Square Distribution | 1 | 2016 | 318 | 0.130 |
Why?
| Gastrointestinal Agents | 1 | 2015 | 36 | 0.130 |
Why?
| Remission Induction | 1 | 2015 | 221 | 0.130 |
Why?
| Clinical Competence | 1 | 2017 | 446 | 0.120 |
Why?
| Odds Ratio | 1 | 2016 | 604 | 0.120 |
Why?
| Patient Care Team | 1 | 2016 | 273 | 0.120 |
Why?
| Immunologic Factors | 1 | 2015 | 130 | 0.120 |
Why?
| Infant, Newborn | 1 | 2021 | 2907 | 0.120 |
Why?
| Models, Statistical | 1 | 2015 | 259 | 0.120 |
Why?
| Anti-Bacterial Agents | 1 | 2019 | 820 | 0.120 |
Why?
| Pregnancy | 1 | 2021 | 2620 | 0.110 |
Why?
| Thrombosis | 1 | 2015 | 243 | 0.110 |
Why?
| Logistic Models | 1 | 2016 | 995 | 0.110 |
Why?
| Infant | 1 | 2021 | 3817 | 0.110 |
Why?
| Case-Control Studies | 1 | 2016 | 1228 | 0.110 |
Why?
| Child, Preschool | 1 | 2021 | 4147 | 0.110 |
Why?
| Residential Facilities | 1 | 2010 | 11 | 0.090 |
Why?
| Adolescent | 4 | 2017 | 6897 | 0.090 |
Why?
| Physician Executives | 1 | 2010 | 17 | 0.090 |
Why?
| Nurse Administrators | 1 | 2010 | 23 | 0.090 |
Why?
| Up-Regulation | 2 | 2021 | 508 | 0.090 |
Why?
| Activities of Daily Living | 1 | 2010 | 204 | 0.080 |
Why?
| Necrosis | 2 | 2021 | 208 | 0.080 |
Why?
| Biopsy | 2 | 2021 | 692 | 0.070 |
Why?
| Feasibility Studies | 2 | 2019 | 398 | 0.070 |
Why?
| Prognosis | 2 | 2021 | 2118 | 0.070 |
Why?
| Computer Literacy | 1 | 2004 | 5 | 0.060 |
Why?
| India | 1 | 2004 | 79 | 0.060 |
Why?
| Obesity | 2 | 2023 | 1202 | 0.060 |
Why?
| Random Allocation | 1 | 2004 | 312 | 0.060 |
Why?
| Cross-Sectional Studies | 2 | 2010 | 1693 | 0.060 |
Why?
| Data Collection | 1 | 2004 | 321 | 0.050 |
Why?
| Portal Pressure | 1 | 2021 | 3 | 0.050 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2022 | 169 | 0.050 |
Why?
| Portal Vein | 1 | 2021 | 30 | 0.050 |
Why?
| Double-Blind Method | 1 | 2023 | 742 | 0.050 |
Why?
| Early Detection of Cancer | 1 | 2023 | 162 | 0.050 |
Why?
| Software | 1 | 2004 | 296 | 0.050 |
Why?
| Clinical Enzyme Tests | 1 | 2020 | 3 | 0.050 |
Why?
| Decontamination | 1 | 2020 | 9 | 0.050 |
Why?
| Teaching Rounds | 1 | 2020 | 7 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 206 | 0.050 |
Why?
| Peptic Ulcer Hemorrhage | 1 | 2020 | 3 | 0.050 |
Why?
| Anastomosis, Roux-en-Y | 1 | 2020 | 4 | 0.050 |
Why?
| Renal Dialysis | 1 | 2022 | 192 | 0.050 |
Why?
| Personnel Staffing and Scheduling | 1 | 2020 | 29 | 0.050 |
Why?
| Follow-Up Studies | 2 | 2017 | 2387 | 0.050 |
Why?
| Uncertainty | 1 | 2020 | 46 | 0.050 |
Why?
| Ultrasonography, Interventional | 1 | 2021 | 146 | 0.050 |
Why?
| Ulcer | 1 | 2020 | 23 | 0.050 |
Why?
| Congresses as Topic | 1 | 2020 | 52 | 0.050 |
Why?
| Genomics | 1 | 2022 | 310 | 0.050 |
Why?
| Overweight | 1 | 2023 | 240 | 0.050 |
Why?
| Blood Transfusion | 1 | 2021 | 138 | 0.050 |
Why?
| Infection Control | 1 | 2020 | 57 | 0.050 |
Why?
| Education, Distance | 1 | 2020 | 39 | 0.050 |
Why?
| Data Interpretation, Statistical | 1 | 2021 | 177 | 0.050 |
Why?
| Erythrocyte Transfusion | 1 | 2020 | 74 | 0.050 |
Why?
| Proton Pump Inhibitors | 1 | 2020 | 84 | 0.040 |
Why?
| Body Mass Index | 1 | 2023 | 713 | 0.040 |
Why?
| Esophageal Motility Disorders | 1 | 2019 | 1 | 0.040 |
Why?
| Cholecystostomy | 1 | 2019 | 10 | 0.040 |
Why?
| Immunocompromised Host | 1 | 2020 | 130 | 0.040 |
Why?
| Linear Models | 2 | 2010 | 309 | 0.040 |
Why?
| Fellowships and Scholarships | 1 | 2020 | 117 | 0.040 |
Why?
| Health Policy | 1 | 2020 | 171 | 0.040 |
Why?
| Antiviral Agents | 1 | 2020 | 188 | 0.040 |
Why?
| Intubation, Intratracheal | 1 | 2020 | 130 | 0.040 |
Why?
| Anxiety | 1 | 2020 | 279 | 0.040 |
Why?
| Dilatation, Pathologic | 1 | 2018 | 22 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2019 | 161 | 0.040 |
Why?
| Deglutition Disorders | 1 | 2019 | 71 | 0.040 |
Why?
| Nitrous Oxide | 1 | 2017 | 12 | 0.040 |
Why?
| Tumor Burden | 1 | 2018 | 142 | 0.040 |
Why?
| Metals | 1 | 2017 | 44 | 0.040 |
Why?
| Retreatment | 1 | 2017 | 57 | 0.040 |
Why?
| Prosthesis Design | 1 | 2018 | 262 | 0.040 |
Why?
| Biomedical Research | 1 | 2020 | 240 | 0.040 |
Why?
| Cardia | 1 | 2016 | 10 | 0.040 |
Why?
| Risk | 1 | 2018 | 343 | 0.040 |
Why?
| Treatment Failure | 1 | 2017 | 139 | 0.040 |
Why?
| Incidental Findings | 1 | 2017 | 42 | 0.040 |
Why?
| Esophagogastric Junction | 1 | 2017 | 30 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2020 | 1304 | 0.040 |
Why?
| Tomography, Optical Coherence | 1 | 2018 | 148 | 0.040 |
Why?
| Observer Variation | 1 | 2016 | 138 | 0.040 |
Why?
| Biopsy, Needle | 1 | 2017 | 195 | 0.040 |
Why?
| Academic Medical Centers | 1 | 2017 | 141 | 0.040 |
Why?
| Patient Safety | 1 | 2017 | 121 | 0.030 |
Why?
| Adenoma | 1 | 2018 | 142 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2020 | 644 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 259 | 0.030 |
Why?
| Gastrostomy | 1 | 2016 | 60 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 923 | 0.030 |
Why?
| Algorithms | 1 | 2019 | 697 | 0.030 |
Why?
| Reoperation | 1 | 2017 | 454 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 913 | 0.030 |
Why?
| Telemedicine | 1 | 2020 | 449 | 0.030 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2015 | 180 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2017 | 1089 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2018 | 1213 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2018 | 1604 | 0.020 |
Why?
| Physician-Nurse Relations | 1 | 2010 | 3 | 0.020 |
Why?
| Nursing Staff | 1 | 2010 | 31 | 0.020 |
Why?
| Institutionalization | 1 | 2010 | 11 | 0.020 |
Why?
| Fee-for-Service Plans | 1 | 2010 | 11 | 0.020 |
Why?
| Statistics as Topic | 1 | 2010 | 103 | 0.020 |
Why?
| Health Care Surveys | 1 | 2010 | 195 | 0.020 |
Why?
| Ambulatory Care | 1 | 2010 | 230 | 0.020 |
Why?
| Quality of Health Care | 1 | 2010 | 222 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 635 | 0.020 |
Why?
| Communication | 1 | 2010 | 273 | 0.020 |
Why?
|
|
Inamdar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|